MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-23-0009005
Besi Drugs Pvt Ltd - chemicals and materials in Dindori, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹11.1 Cr
▲ 10% YoY
Net profit · FY 2025
₹39.48 Lakh
Net margin 3.6%
EBITDA · FY 2025
₹1.24 Cr
EBITDA margin 11.2%
Authorised capital
₹7 Lakh
Registered with MCA
Paid-up capital
₹6.3 Lakh
Issued & subscribed
Open charges
₹2.04 Cr
Satisfied ₹23.45 Lakh
Company age
36 yrs
Est. 1990
Directors on board
2
As per MCA filings
About Besi Drugs Pvt Ltd
Data last updated:
Besi Drugs Pvt Ltd is a private limited company based in Dindori, Maharashtra, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 19 December 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1990PTC059485. Its GSTIN is 27AABCB1056D1Z8 (Maharashtra).
The company has an authorised share capital of ₹7 Lakh and a paid-up capital of ₹6.3 Lakh. It is led by directors Nirmal Vinodkumar Patel and Vinod Bhagwandas Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gut No. 200/1 Post Lakhamapur, Dindori, Maharashtra, India – 422202.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.1 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹39.48 Lakh (net margin 3.6%) and EBITDA of ₹1.24 Cr (EBITDA margin 11.2%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 23% over five years.
As per MCA filings, the company has open charges of ₹2.04 Cr and satisfied charges of ₹23.45 Lakh on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 1 case is pending.
Besi Drugs Pvt Ltd is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-23-0009005). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website besidrugsindia.com.
Company details
CIN U24230MH1990PTC059485
Registration Number 059485
Incorporation Date 19 December 1990
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-23-0009005
Recognitions & Rankings of Besi Drugs
Contact details
Besi Drugs Pvt Ltd's registered office is in Dindori, Maharashtra. Its website is besidrugsindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressGut No. 200/1 Post Lakhamapur, Dindori, Maharashtra, India – 422202
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Besi Drugs Pvt Ltd, buy the company report.
Comprehensive company report
Besi Drugs Pvt Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Besi Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Besi Drugs Pvt Ltd, buy the company report.
Financials of Besi Drugs Pvt Ltd
FY 2025 filings availableBesi Drugs Pvt Ltd reported revenue of ₹11.1 Cr (up 10% YoY) for FY 2025.
Revenue · FY 2025
₹11.1 Cr ▲ 10%
Net profit · FY 2025
₹39.48 Lakh margin 3.6%
EBITDA · FY 2025
₹1.24 Cr margin 11.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 13%
5 years · compounded
▲ 23%
EBITDA CAGR growth
1 year
▲ 53%
3 years · compounded
▲ 40%
5 years · compounded
▲ 48%
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 10% growth in the latest year. EBITDA rose 53% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.24 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹39.48 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.2% | ||||
| Net Profit Margin | 3.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Besi Drugs Pvt Ltd, buy the company report.
Board of directors of Besi Drugs Pvt Ltd
Besi Drugs has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nirmal Vinodkumar Patel | Director | 07 Jan 2019 | 7 Years 10 Months | Current |
| Vinod Bhagwandas Patel | Director | 19 Dec 1990 | 35 Years 10 Months | Current |
Auditor
Besi Drugs Pvt Ltd is audited by Ekbote Deshmukh & Company for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Ekbote Deshmukh & Company | FY 2022 | 118553W |
Shareholding
The shareholding of Besi Drugs Pvt Ltd is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Besi Drugs Pvt Ltd, buy the company report.
Charges & borrowings
Open charges
₹2.04 Cr
Satisfied charges
₹23.45 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Dec 2023 | 100836971 | Axis Bank Limited | ₹1.15 Cr | Open | |
| 27 Nov 2023 | 100846669 | Axis Bank Limited | ₹14 Lakh | Open | |
| 06 Jun 2023 | 100760945 | Axis Bank Limited | ₹75 Lakh | Open | |
| 23 May 1992 | 90162615 | The Nasik Merchant Co-Op Bank Ltd | ₹25,000 | Open | |
| 23 Feb 1993 | 90160669 | Maharashtra Stae Financila Corp. | ₹18.45 Lakh | Satisfied |
To see the full charge records of Besi Drugs Pvt Ltd, buy the company report.
Total charge records: 6 View all charges
Legal cases
Besi Drugs Pvt Ltd has 2 court cases on record: 1 filed by Besi Drugs, 1 filed against it. 1 case is pending and 1 is disposed.
Total cases
2
Filed by the company
1
Filed against the company
1
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 1 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Tax appeal | Filed against the company by PR. Commissioner of Income Tax-6 | Pending |
| Bombay High Court | Court case (SS) | Filed by the company against M/S Cadila Healthcare Ltd . | Disposed |
To see the full case history of Besi Drugs Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Besi Drugs Pvt Ltd has 2 MSME Form 1 returns on record between 2020 and 2021, listing 23 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 5)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Vipson Chemical Industries | |||
| Sunil Great (Hosiery Yarn and Kapadia) Processors Pvt Ltd | |||
| Mehk Chemicals Pvt Ltd | |||
| Premier Intermediates Limited | |||
| Lok Chemicals Private Limited |
To see the full MSME payment records of Besi Drugs Pvt Ltd, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Besi Drugs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCB1056D1Z8 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Besi Drugs Pvt Ltd, buy the company report.
Recent activity
Besi Drugs Pvt Ltd has 4 board changes on record since 1990: 2 appointments and 2 cessations. The latest: Nirmal Vinodkumar Patel ceased to be Additional Director on 30 Sep 2019.
AGM
Besi Drugs Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Besi Drugs Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Axis Bank Limited amounted to Rs. 115.00 Lakh with Charge ID 100836971 was registered on 19 Dec 2023.
Charges
A charge with Axis Bank Limited amounted to Rs. 14.00 Lakh with Charge ID 100846669 was registered on 27 Nov 2023.
Charges
A charge with Axis Bank Limited amounted to Rs. 75.00 Lakh with Charge ID 100760945 was registered on 06 Jun 2023.
Charges
A charge registered on 23 Feb 1993 via Charge ID 90160669 with Maharashtra Stae Financila Corp. was fully satisfied on 27 Aug 2020.
Charges
A charge registered on 25 May 1992 via Charge ID 90162616 with Maharashtra Stae Financila Corp. was fully satisfied on 27 Aug 2020.
Ceased
Nirmal Vinodkumar Patel ceased to be Additional Director.
Ceased
Jaykumar Sarupchand Sandesara ceased to be Director.
Appointed
Nirmal Vinodkumar Patel was appointed as Director.
Charges
A charge with Maharashtra Stae Financila Corp. amounted to Rs. 18.45 Lakh with Charge ID 90160669 was registered on 23 Feb 1993.
Charges
A charge with Maharashtra Stae Financila Corp. amounted to Rs. 5.00 Lakh with Charge ID 90162616 was registered on 25 May 1992.
3 earlier events are in the company report.
Frequently asked questions
Besi Drugs is an active private limited company based in Dindori, Maharashtra, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 19 December 1990 (36+ years old) and is registered under CIN U24230MH1990PTC059485.
Besi Drugs has 2 current directors:
- Nirmal Vinodkumar Patel - Director
- Vinod Bhagwandas Patel - Director
The latest financial statements of Besi Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Besi Drugs is 27AABCB1056D1Z8, registered in Maharashtra.
The CIN (Corporate Identification Number) of Besi Drugs is U24230MH1990PTC059485. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Besi Drugs has 2 court cases on record: 1 filed by the company and 1 filed against it. 1 is pending.
Besi Drugs was incorporated on 19 December 1990, making it 36+ years old. It is registered with the Registrar of Companies, Mumbai.
Nirmal Vinodkumar Patel ceased to be Additional Director on 30 Sep 2019. Jaykumar Sarupchand Sandesara ceased to be Director on 07 Jan 2019. Nirmal Vinodkumar Patel was appointed as Director on 07 Jan 2019. Besi Drugs has 4 board changes on record in total.
Yes, Besi Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-MH-23-0009005).
Besi Drugs has 2 MSME Form 1 returns on record between 2020 and 2021, listing 23 overdue payments to 5 micro and small suppliers. The latest return was filed on 13 May 2021.
Besi Drugs can be reached through the website besidrugsindia.com. Its registered office is in Dindori, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages